Your browser doesn't support javascript.
loading
The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis.
McQuaid, C Finn; Horton, Katherine C; Dean, Anna S; Knight, Gwenan M; White, Richard G.
Afiliação
  • McQuaid CF; TB Modelling Group, TB Centre, AMR Centre and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK finn.mcquaid@lshtm.ac.uk.
  • Horton KC; TB Modelling Group, TB Centre and Centre for Mathematical Modelling of Infectious Diseases, Dept of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Dean AS; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Knight GM; TB Modelling Group, TB Centre, AMR Centre and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • White RG; TB Modelling Group, TB Centre and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Eur Respir J ; 56(3)2020 09.
Article em En | MEDLINE | ID: mdl-32430421
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article